In a report released on October 22, David Evans from Kepler Capital maintained a Buy rating on Novartis AG (NOVN – Research Report), ...

Infertility Drugs MarketThe global infertility drugs market is set for significant growth over the next decade, with the ...

Shares of Incyte have risen 3.9% in the year-to-date period against the industry’s decline of 1.8%. Incyte primarily derives product revenues from the sales of its lead drug, Jakafi (ruxolitinib), in ...

On Friday, Novartis AG (NYSE:NVS) announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for ...

A Maryland drug affordability board can move forward with a plan to cap how much the state and local governments pay for ...

If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible for adjuvant treatment ...

BP’s program includes a novel PSMA-binding molecule that may be a potential next-generation radioligand therapy (RLT) for prostate cancer and is currently being studied in two investigator-initiated ...

US private equity firm Clayton Dubilier & Rice thought it had a deal to buy Sanofi’s consumer business. Losing bidder PAI ...

Check the time stamp on this data. Updated AI-Generated Signals for Novartis Ag (NVS) available here: NVS.

Eisenmenger Complex Management MarketThe global Eisenmenger Complex Management Market is poised for significant growth, projected to exceed USD 12.9 Billion by 2033, up from USD 7.7 Billion in 2023, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...